As emphasized by Ristow and colleagues, treatments for obesity and diabetes with associated insulin resistance are based on the idea that increasing insulin sensitive glucose uptake, with a consequent lowering of blood glucose, will improve health outcomes. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.